The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of TP53 mutation status with clinical outcomes stratified by sensitive and non sensitive EGFR mutation, in non-small cell lung cancer (NSCLC).
 
Saman Ahmed
No Relationships to Disclose
 
Charu Aggarwal
No Relationships to Disclose
 
Rosemarie Mick
Consulting or Advisory Role - Elekta
 
Trisha M Sterlicchi
No Relationships to Disclose
 
Stephan Kadauke
No Relationships to Disclose
 
Christofer Gault
No Relationships to Disclose
 
Roger B. Cohen
Consulting or Advisory Role - Heat Biologics
Research Funding - Heat Biologics (Inst)
Travel, Accommodations, Expenses - Heat Biologics
 
Tracey L. Evans
Honoraria - Celgene; Genentech; Genentech (I); Lilly
Consulting or Advisory Role - Celgene; Genentech; Genentech (I); Lilly
Speakers' Bureau - Genentech (I)
Research Funding - Sanofi
Travel, Accommodations, Expenses - Celgene; Genentech; Genentech (I); Lilly; Sanofi
 
Joshua Bauml
Research Funding - Merck (Inst)
 
Charuhas Deshpande
Stock and Other Ownership Interests - ARIAD; Foundation Medicine; Illumina
 
Drew A. Torigian
No Relationships to Disclose
 
Jayaram Udupa
No Relationships to Disclose
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; Bayer/Onyx; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck; Millennium
Research Funding - Advantagene (Inst); Ariad (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst)
 
Jennifer J. Morrissette
No Relationships to Disclose